LYFCX
Price
$11.90
Change
+$0.02 (+0.17%)
Updated
Jun 30 closing price
Net Assets
34.6M
THISX
Price
$77.46
Change
+$0.32 (+0.41%)
Updated
Jun 30 closing price
Net Assets
11.27B
Interact to see
Advertisement

LYFCX vs THISX

Header iconLYFCX vs THISX Comparison
Open Charts LYFCX vs THISXBanner chart's image
AlphaCentric Life Sciences & Hlthcare C
Price$11.90
Change+$0.02 (+0.17%)
VolumeN/A
Net Assets34.6M
T. Rowe Price Health Sciences I
Price$77.46
Change+$0.32 (+0.41%)
VolumeN/A
Net Assets11.27B
LYFCX vs THISX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LYFCX vs. THISX commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYFCX is a StrongSell and THISX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
THISX has more cash in the bank: 11.3B vs. LYFCX (34.6M). LYFCX pays higher dividends than THISX: LYFCX (1.21) vs THISX (0.19). LYFCX was incepted earlier than THISX: LYFCX (6 years) vs THISX (9 years). LYFCX (2.66) is less costly to investors than THISX (0.67). LYFCX is a more actively managed with annual turnover of: 164.00 vs. THISX (52.40). LYFCX has a lower initial minimum investment than THISX: LYFCX (2500) vs THISX (500000). LYFCX annual gain was more profitable for investors over the last year : 1.38 vs. THISX (-18.80). LYFCX return over 5 years is better than : 6.22 vs. THISX (-11.87).
LYFCXTHISXLYFCX / THISX
Total Expense Ratio2.410.67360%
Annual Report Gross Expense Ratio2.660.67397%
Fund Existence6 years9 years-
Gain YTD-3.415-3.224106%
Front LoadN/AN/A-
Min. Initial Investment25005000001%
Min. Initial Investment IRAN/AN/A-
Net Assets34.6M11.3B0%
Annual Yield % from dividends1.210.19642%
Returns for 1 year1.38-18.80-7%
Returns for 3 years0.95-11.22-8%
Returns for 5 years6.22-11.87-52%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BAFMX18.02N/A
N/A
Brown Advisory Mid-Cap Growth Instl
FFAAX16.54N/A
N/A
Franklin Global Allocation Adv
AUUCX20.22N/A
N/A
AB Select US Equity C
OANMX160.40N/A
N/A
Oakmark Institutional
RYTCX7.74-0.01
-0.13%
Royce Small-Cap Total Return Consult